cevimeline hydrochloride
Generic: cevimeline hydrochloride
Labeler: pd-rx pharmaceuticals, inc.Drug Facts
Product Profile
Brand Name
cevimeline hydrochloride
Generic Name
cevimeline hydrochloride
Labeler
pd-rx pharmaceuticals, inc.
Dosage Form
CAPSULE
Routes
Active Ingredients
cevimeline hydrochloride 30 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
72789-457
Product ID
72789-457_48d8a76e-8103-9485-e063-6294a90af9ab
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA216682
Listing Expiration
2027-12-31
Marketing Start
2023-04-06
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
72789457
Hyphenated Format
72789-457
Supplemental Identifiers
RxCUI
UNII
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
cevimeline hydrochloride (source: ndc)
Generic Name
cevimeline hydrochloride (source: ndc)
Application Number
ANDA216682 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 30 mg/1
Packaging
- 100 CAPSULE in 1 BOTTLE, PLASTIC (72789-457-01)
- 30 CAPSULE in 1 BOTTLE, PLASTIC (72789-457-30)
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "48d8a76e-8103-9485-e063-6294a90af9ab", "openfda": {"unii": ["P81Q6V85NP"], "rxcui": ["309140"], "spl_set_id": ["2b429ea7-1c7c-47a4-803c-2546736f5c36"], "manufacturer_name": ["PD-Rx Pharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE, PLASTIC (72789-457-01)", "package_ndc": "72789-457-01", "marketing_start_date": "20241230"}, {"sample": false, "description": "30 CAPSULE in 1 BOTTLE, PLASTIC (72789-457-30)", "package_ndc": "72789-457-30", "marketing_start_date": "20241230"}], "brand_name": "CEVIMELINE HYDROCHLORIDE", "product_id": "72789-457_48d8a76e-8103-9485-e063-6294a90af9ab", "dosage_form": "CAPSULE", "pharm_class": ["Cholinergic Muscarinic Agonists [MoA]", "Cholinergic Receptor Agonist [EPC]"], "product_ndc": "72789-457", "generic_name": "CEVIMELINE HYDROCHLORIDE", "labeler_name": "PD-Rx Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CEVIMELINE HYDROCHLORIDE", "active_ingredients": [{"name": "CEVIMELINE HYDROCHLORIDE", "strength": "30 mg/1"}], "application_number": "ANDA216682", "marketing_category": "ANDA", "marketing_start_date": "20230406", "listing_expiration_date": "20271231"}